SCHEMBL8749579

SCHEMBL8749579

COc1ccc(-c2oc3ccc(O)c(O)c3c(=O)c2O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.70
CYP1A1 P04798 2/20 0.70
CYP1A2 P05177 2/20 0.70
CYP1B1 Q16678 2/20 0.70
ABCB1 P08183 1/20 0.70
FTO Q9C0B1 1/20 0.70
ABCG2 Q9UNQ0 2/20 0.67
CYP3A4 P08684 5/20 0.63
KDM4E B2RXH2 4/20 0.63
MAPT P10636 4/20 0.63
HSD17B10 Q99714 3/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
ALDH1A1 P00352 2/20 0.63
TP53 P04637 2/20 0.63
CASP1 P29466 2/20 0.63
CASP7 P55210 2/20 0.63
HPGD P15428 1/20 0.63
CSNK2A2 P19784 1/20 0.62
CSNK2B P67870 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28316302 0.87 MAPT (0.63) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL28747747 0.87 ABCG2 (0.72) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL9665640 0.86 MAOA (0.74) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL6535222 0.84 MAOA (0.72) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL28563029 0.84 MAPT (0.67) MAOACYP1A1CYP1A2CYP1B1ABCB1
Betuletol SCHEMBL29400938 0.84 TUBB4A (0.86) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL28430943 0.84 TP53 (0.60) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL748643 0.83 MAOA (0.90) MAOACYP1A1CYP1A2CYP1B1ABCB1
SCHEMBL20798544 0.83 MEN1 (0.68) MAOACYP1A1CYP1A2CYP1B1ABCB1
Kaempferide SCHEMBL29371282 0.82 CYP1A2 (1.00) MAOACYP1A1CYP1A2CYP1B1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230322-A1 ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF ELAMIPRETIDE STEALTH BIOTHERAPEUTICS INC. (US) 2023-11-30 WO claimed
CN-113801084-B Polymethoxy flavone extracted from orange vinegar fermentation substrate sludge, extraction method and application 三峡大学 2023-11-28 CN disclosed
CN-114317630-A Preparation method of diosmetin 成都欧康医药股份有限公司 2022-04-12 CN disclosed
CN-111100104-B Preparation method of diosmetin 陕西嘉禾药业有限公司 2022-04-01 CN disclosed
CN-110279758-B Peony leaf dry powder, preparation method thereof and application of peony leaf dry powder as xanthine oxidase inhibitor 陕西凤丹正元生物科技有限公司 2022-02-01 CN disclosed
CN-113801084-A Polymethoxyflavone extracted from orange vinegar fermentation substrate sludge, and extraction method and application thereof 三峡大学 2021-12-17 CN disclosed
CN-113018294-A Application of diosmetin 西北农林科技大学 2021-06-25 CN disclosed
CN-109180627-B Semi-synthesis method of diosmetin 陕西嘉禾生物科技股份有限公司 2020-11-10 CN disclosed
CN-111100104-A Preparation method of diosmetin 陕西嘉禾药业有限公司 2020-05-05 CN disclosed
US-20190203240-A1 METHODS FOR THE PRODUCTION OF RHAMNOSYLATED FLAVONOIDS UNIV HAMBURG (DE) 2019-07-04 US disclosed
US-20190100549-A1 FLAVONOIDE-TYPE COMPOUNDS BEARING AN O-RHAMNOSYL RESIDUE UNIVERSITAET HAMBURG (DE) 2019-04-04 US disclosed
EP-3402788-A1 FLAVONOIDE-TYPE COMPOUNDS BEARING AN O-RHAMNOSYL RESIDUE Universität Hamburg (DE) 2018-11-21 EP disclosed
EP-3402893-A1 METHODS FOR THE PRODUCTION OF RHAMNOSYLATED FLAVONOIDS Universität Hamburg (DE) 2018-11-21 EP disclosed
WO-2017121855-A1 FLAVONOIDE-TYPE COMPOUNDS BEARING AN O-RHAMNOSYL RESIDUE UNIVERSITÄT HAMBURG (DE) 2017-07-20 WO disclosed
WO-2017121863-A1 METHODS FOR THE PRODUCTION OF RHAMNOSYLATED FLAVONOIDS UNIVERSITÄT HAMBURG (DE) 2017-07-20 WO disclosed
EP-0420232-B1 Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions EUROP PHARMACY SRL (IT) 1997-03-26 EP disclosed
EP-0420232-A2 Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions EUROPEAN PHARMACY Srl (IT) 1991-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190100549-A1 FLAVONOIDE-TYPE COMPOUNDS BEARING AN O-RHAMNOSYL RESIDUE LRAT, TYR, CUTA MAOA 62/4885CYP1A1 127/4885CYP1A2 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.